[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX9707695A - Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation. - Google Patents

Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation.

Info

Publication number
MX9707695A
MX9707695A MX9707695A MX9707695A MX9707695A MX 9707695 A MX9707695 A MX 9707695A MX 9707695 A MX9707695 A MX 9707695A MX 9707695 A MX9707695 A MX 9707695A MX 9707695 A MX9707695 A MX 9707695A
Authority
MX
Mexico
Prior art keywords
aqueous solution
procaterol hydrochloride
solution formulation
hydrochloride aqueous
package holding
Prior art date
Application number
MX9707695A
Other languages
Spanish (es)
Inventor
Yuzo Kimura
Shinichi Ishikawa
Masafumi Toda
Takakuni Matsuda
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX9707695A publication Critical patent/MX9707695A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

An object of the present invention is to impart long-term storage stability to a pharmaceutical composition comprising an aqueous solution of procaterol hydrochloride. This invention is directed to an aqueous solution of procaterol hydrochloride which assures that the procaterol hydrochloride is kept from decomposing in the aqueous solution due to its oxidation reaction.
MX9707695A 1995-04-04 1996-03-25 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation. MX9707695A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7856495 1995-04-04
PCT/JP1996/000772 WO1996031195A1 (en) 1995-04-04 1996-03-25 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation

Publications (1)

Publication Number Publication Date
MX9707695A true MX9707695A (en) 1997-12-31

Family

ID=13665401

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707695A MX9707695A (en) 1995-04-04 1996-03-25 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation.

Country Status (7)

Country Link
EP (1) EP0820274A1 (en)
KR (1) KR19980703582A (en)
AR (1) AR002981A1 (en)
AU (1) AU5015296A (en)
CA (1) CA2217360A1 (en)
MX (1) MX9707695A (en)
WO (1) WO1996031195A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004530644A (en) * 2000-12-21 2004-10-07 アルコン、インコーポレイテッド Artificial tear composition suitable for use with contact lenses
US9636355B2 (en) 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
PL3139903T3 (en) * 2014-05-07 2019-12-31 Croma-Pharma Gesellschaft M.B.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
EP3342398A4 (en) * 2015-10-06 2019-03-20 G-Treebnt Co., Ltd. Method for preparing ophthalmic preparation containing thymosin beta-4
RU2743274C9 (en) * 2015-11-10 2021-04-08 Общество с ограниченной ответственностью "ДИАМЕД-фарма" Pharmaceutical preparation for treatment of arthrological diseases
RU2612019C1 (en) * 2015-12-11 2017-03-01 Общество с ограниченной ответственностью "ДИАМЕД-фарма" Production method of preparation injectable form based on sulfate chondroitin
CN114159398B (en) * 2021-03-22 2023-05-23 南京艾德加生物制药科技有限公司 Procaterol hydrochloride oral solid composition and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2638156B2 (en) * 1988-11-11 1997-08-06 優樹 小田切 Pharmaceutical composition
JP3390477B2 (en) * 1993-01-25 2003-03-24 生化学工業株式会社 Pharmaceutical composition and method for producing the same

Also Published As

Publication number Publication date
WO1996031195A1 (en) 1996-10-10
AU5015296A (en) 1996-10-23
EP0820274A1 (en) 1998-01-28
KR19980703582A (en) 1998-11-05
AR002981A1 (en) 1998-05-27
CA2217360A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
EP1135173A4 (en) A medicinal aerosol formulation
US6136294C1 (en) Amino acid stabilized medical aerosol formulation
ES2097546T3 (en) DEODORANT COSMETIC PREPARATIONS CONTAINING DI- OR TRIGLYCERID ESTERS.
ZA955546B (en) Multiple unit tableted dosage form II
CO5580776A2 (en) STABLE PHARMACEUTICAL FORMULATION IN SOLUTION OF OXALIPLATIN
DK0717617T3 (en) Microparticles containing active ingredients and gas
MXPA03000442A (en) A medicinal aerosol formulation.
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
EP0251369A3 (en) Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them
IE873125L (en) Benzimidazole derivatives
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.
PL346764A1 (en) New oral formulation for 5-ht4
BR9707551A (en) Compositions containing an antifungal and a sulfur compound.
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
MX9700470A (en) Use of glyceryl triacetate for treating onychomycoses.
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
MX9504023A (en) Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid.
MX9707695A (en) Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation.
GB9505082D0 (en) Medicament
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
DE59205998D1 (en) Medicament with antineoplastic activity containing octadecyl- [2- (N-methylpiperidino) ethyl] phosphate as active ingredient and process for its preparation
DK8291A (en) COMPOSITION comprising an active ingredient, preferably in powder or particulate form, as well as a carrier for the active ingredient and process for the preparation of such preparation
MY152490A (en) New oral formulation